Last updated on October 2017

Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease


Brief description of study

Purpose of study is to aim to confirm efficacy and safety of osilodrostat for the treatment of patients with Cushing's disease who are candidates for medical therapy

Clinical Study Identifier: NCT02697734

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Adina Turcu

University of Michigan Comprehensive Cancer Center
Ann Arbor, MI United States
  Connect »

Julie Silverstein

Washington University School of Medicine
Saint Louis, MO United States
  Connect »

Pamela U. Freda

Columbia University Medical Center- New York Presbyterian Neuroendocrine Unit
New York, NY United States
  Connect »

Eliza B. Geer

Memorial Sloan Kettering Cancer Cancer
New York, NY United States
  Connect »

Joseph A. Aloi

Wake Forest University Baptist Medical Center
Winston-Salem, NC United States
  Connect »

Peter J. Snyder

University of Pennsylvania Medical Center University of Pennsylvania
Philadelphia, PA United States
  Connect »

Monika Shirodkar

Thomas Jefferson University Hospital
Philadelphia, PA United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Gent, Belgium
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Leuven, Belgium
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Fortaleza, Brazil
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Rio de Janeiro, Brazil
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Sao Paulo, Brazil
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Athens, Greece
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Warszawa, Poland
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Krakow, Poland
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Poznan, Poland
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Wroclaw, Poland
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Porto, Portugal
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Moscow, Russian Federation
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Malaga, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Barcelona, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Alzira, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Valencia, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
La Coruna, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Luzern, Switzerland
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bangkok, Thailand
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Ankara, Turkey
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Istanbul, Turkey
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Kocaeli, Turkey
  Connect »